# Clinical Impact of Acthar in the Psoriatic Arthritis Patient (CLIPS)

> **NCT03419650** · PHASE4 · COMPLETED · sponsor: **IRIS Research and Development, LLC** · enrollment: 10 (actual)

## Conditions studied

- Psoriatic Arthritis

## Interventions

- **DRUG:** ACTHar

## Key facts

- **NCT ID:** NCT03419650
- **Lead sponsor:** IRIS Research and Development, LLC
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-20
- **Primary completion:** 2021-08-25
- **Final completion:** 2021-08-25
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2021-08-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03419650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03419650, "Clinical Impact of Acthar in the Psoriatic Arthritis Patient (CLIPS)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03419650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*